Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Recruiting 4Active not recruiting 3Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 298Neoplasms 179Breast Neoplasms 170Colorectal Neoplasms 107Neoplasm Metastasis 100Melanoma 99Multiple Myeloma 93Prostatic Neoplasms 90Ovarian Neoplasms 83Recurrence 80Carcinoma, Renal Cell 73Lung Neoplasms 71Stomach Neoplasms 67Squamous Cell Carcinoma of Head and Neck 67Lymphoma, Non-Hodgkin 61Pancreatic Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 56Leukemia, Myeloid, Acute 54Carcinoma, Hepatocellular 48Triple Negative Breast Neoplasms 47Small Cell Lung Carcinoma 46Urinary Bladder Neoplasms 45Lymphoma, Large B-Cell, Diffuse 43Head and Neck Neoplasms 41Endometrial Neoplasms 41Lymphoma, Follicular 39Lymphoma 37Uterine Cervical Neoplasms 35Parkinson Disease 4, Autosomal Dominant Lewy Body 34Glioblastoma 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × Advanced Solid Cancer × Clear all
NCT05947474 2026-02-10

ORB

Orionis Biosciences Inc

Phase 1 Active not recruiting
55 enrolled

Advanced Solid Cancer

NCT04877717 2025-03-25

A Study of SHR-A1904 in Patients With Advanced Solid Cancer

Shanghai Hengrui Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
107 enrolled

Advanced Solid Cancer

NCT03791112 2025-01-27

A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor

Betta Pharmaceuticals Co., Ltd.

Phase 1 Active not recruiting
54 enrolled

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡